We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

CombinatoRx and Neuromed Sign Merger Agreement

News   Jul 06, 2009

 
CombinatoRx and Neuromed Sign Merger Agreement
 
 
 

RELATED ARTICLES

New Method to Synthesize and Screen Macrocyclic Compounds

News

Scientists at EPFL have found a way to generate libraries of more than 9,000 of macrocyclic molecules below 1 KDa, all with high structural diversity.

READ MORE

Team Design Drug Molecule to Improve Heart Attack Recovery

News

A new molecule has been developed that could help preserve heart tissue during – and even after – a heart attack.

READ MORE

Drug Targets Early Instigator of Alzheimer's Disease

News

Therapeutic efforts to target "plaques and tangles", considered classic hallmarks of Alzheimer's disease, have previously met with dispiriting failure. Now researchers are exploring a drug called "DYR219" – its strength lies in the fact that it can target both plaques and tangles.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE